DOI QR코드

DOI QR Code

Regional Lymphadenopathy Following COVID-19 Vaccination in Patients with or Suspicious of Breast Cancer: A Quick Summary of Current Key Facts and Recommendations

  • Jung Min Chang (Department of Radiology, Seoul National University Hospital) ;
  • Su Min Ha (Department of Radiology, Seoul National University Hospital)
  • Received : 2022.04.29
  • Accepted : 2022.05.09
  • Published : 2022.07.01

Abstract

Keywords

References

  1. Lane DL, Neelapu SS, Xu G, Weaver O. COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or prior breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT, and PET-CT. Korean J Radiol 2021;22:1938-1945  https://doi.org/10.3348/kjr.2021.0350
  2. Ashoor A, Shephard J, Lissidini G, Nicosia L. Axillary adenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma. Korean J Radiol 2021;22:2124-2126  https://doi.org/10.3348/kjr.2021.0635
  3. Finsterer J. Discrimination between benign and malignant post-SARS-CoV-2 vaccination lymphadenopathy is feasible. Korean J Radiol 2022;23:773-774  https://doi.org/10.3348/kjr.2022.0110
  4. Ashoor A, Shephard J, Lissidini G, Nicosia L. Response to letter; delineation between benign and malign post-SARS-CoV-2 vaccination lymphadenopathy, to our article; axillary adenopathy in patients with recent COVID-19 vaccination: a new diagnostic dilemma. Korean J Radiol 2022;23:775-776  https://doi.org/10.3348/kjr.2022.0207
  5. Ritchie H, Mathieu E, Rodes-Guirao L, Appel C, Giattino C, Ortiz-Ospina E, et al. Coronavirus pandemic (COVID-19). OurWorldInData.org Web site. https://ourworldindata.org/coronavirus. Accessed April 2, 2022
  6. Youn H, Hong KJ. Non-invasive molecular imaging of immune cell dynamics for vaccine research. Clin Exp Vaccine Res 2019;8:89-93  https://doi.org/10.7774/cevr.2019.8.2.89
  7. Burger IA, Husmann L, Hany TF, Schmid DT, Schaefer NG. Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine. Clin Nucl Med 2011;36:848-853  https://doi.org/10.1097/RLU.0b013e3182177322
  8. Casey CG, Iskander JK, Roper MH, Mast EE, Wen XJ, Torok TJ, et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA 2005;294:2734-2743  https://doi.org/10.1001/jama.294.21.2734
  9. Marais BJ, Wright CA, Schaaf HS, Gie RP, Hesseling AC, Enarson DA, et al. Tuberculous lymphadenitis as a cause of persistent cervical lymphadenopathy in children from a tuberculosis-endemic area. Pediatr Infect Dis J 2006;25:142-146  https://doi.org/10.1097/01.inf.0000199259.04970.d1
  10. Studdiford J, Lamb K, Horvath K, Altshuler M, Stonehouse A. Development of unilateral cervical and supraclavicular lymphadenopathy after human papilloma virus vaccination. Pharmacotherapy 2008;28:1194-1197  https://doi.org/10.1592/phco.28.9.1194
  11. Schiaffino S, Pinker K, Magni V, Cozzi A, Athanasiou A, Baltzer PAT, et al. Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI). Insights Imaging 2021;12:119 
  12. Chung Hl, Whitman GJ, Leung JWT, Sun J, Middleton LP, Le-Petross HT. Ultrasound features to differentiate COVID-19 vaccine-induced benign adenopathy from breast cancer related malignant adenopathy. Acad Radiol 2022;29:1004-1012  https://doi.org/10.1016/j.acra.2022.02.015
  13. Park JY, Lee JY, Yi SY. Axillary lymphadenopathy on ultrasound after COVID-19 vaccination and its influencing factors: a single-center study. J Clin Med 2022;11:238 
  14. Wolfson S, Kim E, Plaunova A, Bukhman R, Sarmiento RD, Samreen N, et al. Axillary adenopathy after COVID-19 vaccine: no reason to delay screening mammogram. Radiology 2022;303:297-299  https://doi.org/10.1148/radiol.213227
  15. Adin ME, Isufi E, Kulon M, Pucar D. Association of COVID-19 mRNA vaccine with ipsilateral axillary lymph node reactivity on imaging. JAMA Oncol 2021;7:1241-1242  https://doi.org/10.1001/jamaoncol.2021.1794
  16. Garreffa E, Hamad A, O'Sullivan CC, Hazim AZ, York J, Puri S, et al. Regional lymphadenopathy following COVID-19 vaccination: literature review and considerations for patient management in breast cancer care. Eur J Cancer 2021;159:38-51  https://doi.org/10.1016/j.ejca.2021.09.033
  17. Abe H, Schacht D, Sennett CA, Newstead GM, Schmidt RA. Utility of preoperative ultrasound for predicting pN2 or higher stage axillary lymph node involvement in patients with newly diagnosed breast cancer. AJR Am J Roentgenol 2013;200:696-702  https://doi.org/10.2214/AJR.12.9036
  18. Chang JM, Leung JWT, Moy L, Ha SM, Moon WK. Axillary nodal evaluation in breast cancer: state of the art. Radiology 2020;295:500-515  https://doi.org/10.1148/radiol.2020192534
  19. Ha SM, Cheun JH, Lee SH, Kim SY, Park AR, Kim YS, et al. Ipsilateral lymphadenopathy after COVID-19 vaccination in patients with newly diagnosed breast cancer. J Breast Cancer 2022;25:131-139  https://doi.org/10.4048/jbc.2022.25.e10
  20. Anderson SJ, Wapnir I, Dignam JJ, Fisher B, Mamounas EP, Jeong JH, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol 2009;27:2466-2473  https://doi.org/10.1200/JCO.2008.19.8424
  21. Ha SM, Chu AJ, Lee J, Kim SY, Lee SH, Yoen H, et al. US evaluation of axillary lymphadenopathy following COVID-19 vaccination: a prospective longitudinal study. Radiology 2022 Apr [Epub]. https://doi.org/10.1148/radiol.220543 
  22. Ko G, Hota S, Cil TD. COVID-19 vaccination and breast cancer surgery timing. Breast Cancer Res Treat 2021;188:825-826  https://doi.org/10.1007/s10549-021-06293-6
  23. Weeks JK, O'Brien SR, Rosenspire KC, Dubroff JG, Pantel AR. Evolving bilateral hypermetabolic axillary lymphadenopathy on FDG PET/CT following 2-dose COVID-19 vaccination. Clin Nucl Med 2021;46:1011-1012  https://doi.org/10.1097/RLU.0000000000003711
  24. Hagen C, Nowack M, Messerli M, Saro F, Mangold F, Bode PK. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy. Swiss Med Wkly 2021;151:w20557 
  25. Cocco G, Delli Pizzi A, Taraschi AL, Boccatonda A, Corvino A, Ucciferri C, et al. Atypical sites of lymphadenopathy after anti-COVID-19 vaccine: ultrasound features. Medicina (Kaunas) 2022;58:197 
  26. Park JY, Yi SY. Rare case of contralateral supraclavicular lymphadenopathy after COVID-19 vaccination: computed tomography and ultrasonography findings. Radiol Case Rep 2021;16:3879-3881  https://doi.org/10.1016/j.radcr.2021.09.042
  27. Henderson LM, Ichikawa L, Buist DSM, Lee JM, Bush M, Johnson D, et al. Patterns of breast imaging use among women with a personal history of breast cancer. J Gen Intern Med 2019;34:2098-2106  https://doi.org/10.1007/s11606-019-05181-6
  28. Becker AS, Perez-Johnston R, Chikarmane SA, Chen MM, El Homsi M, Feigin KN, et al. Multidisciplinary recommendations regarding post-vaccine adenopathy and radiologic imaging: Radiology Scientific Expert Panel. Radiology 2021;300:E323-E327 https://doi.org/10.1148/radiol.2021210436